OKYO

OKYO Pharma Limited Ordinary Shares

1.43

USD

+0.03

+2.14%

Nov 06, 15:59 UTC -5

Closed

After-Market

1.41

-0.02

-1.26%

OKYO Pharma Limited Ordinary Shares (OKYO) Earnings

OKYO Earnings Reports

Positive Surprise Ratio

No Data Available for OKYO

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q4 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

OKYO Pharma Limited Ordinary Shares earnings per share and revenue

On Jul 20, 2026, OKYO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.03 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Immunocore Holdings plc - ADR

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.13

Actual

-$0.28

Surprise

-104.08%

Entera Bio Ltd. Ordinary Shares

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.06

Actual

-$0.11

Surprise

-58.50%

Vogenx Inc Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.16

Actual

-$0.47

Surprise

-187.99%

Agenus Inc.

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.27

Actual

$0.02

Surprise

+107.26%

Anika Therapeutics Inc

Report Date

Nov 06, 2026 For Q3 26

Estimate

$0.06

Actual

-$0.02

Surprise

-132.68%

Moderna, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$1.27

Actual

$0.38

Surprise

+129.79%

Bio-Techne Corp.

Report Date

Nov 06, 2026 For Q1 27

Estimate

$0.44

Actual

$0.44

Surprise

-1.96%

Aligos Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$2.21

Actual

-$2.09

Surprise

+5.58%

CervoMed Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.49

Actual

-$0.39

Surprise

+21.97%

Creative Medical Technology Holdings, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.40

Surprise

-63.40%

FAQ

What were OKYO Pharma Limited Ordinary Shares's earnings and revenue for the latest quarter Q4 2026?

For Q4 2026, OKYO Pharma Limited Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to OKYO Pharma Limited Ordinary Shares's Q4 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is OKYO Pharma Limited Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for OKYO Pharma Limited Ordinary Shares's next earnings report?

Based on -- analysts, OKYO Pharma Limited Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.